Cite
HARVARD Citation
Vanderstichele, H. et al. (n.d.). O4‐11‐02: The path to regulatory qualification of cerebrospinal fluid biomarkers as enrichment tools in clinical trials of patients with early Alzheimer's disease: For the coalition against major diseases. Alzheimer's & dementia. p. P296. [Online].